Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06445322

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Sponsor: Ascidian Therapeutics, Inc

View on ClinicalTrials.gov

Summary

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

Official title: Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

Key Details

Gender

All

Age Range

5 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2024-06-20

Completion Date

2030-08-31

Last Updated

2026-03-11

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Prescreening Assessments

Various genetic and visual assessments.

Locations (8)

University of San Francisco

San Francisco, California, United States

Vitreo Retinal Associates

Gainesville, Florida, United States

Wilmer Eye Institute at John Hopkins

Baltimore, Maryland, United States

Massachusetts Eye and Ear

Boston, Massachusetts, United States

University of Michigan Kellogg Eye Center

Ann Arbor, Michigan, United States

Cincinnati Eye Institute

Cincinnati, Ohio, United States

Retina Foundation of Texas

Dallas, Texas, United States

Retina Consultants of Texas

Houston, Texas, United States